FDA lifts partial clinical hold on Mersana’s Phase l study of XMT-1522
The US Food and Drug Administration (FDA) has lifted the partial clinical hold on a...
Read More...
Focus:
X
Focus:
The US Food and Drug Administration (FDA) has lifted the partial clinical hold on a...
Read More...